company is currently valued at 90 million with 30 million in the...

  1. 1,546 Posts.
    lightbulb Created with Sketch. 5
    company is currently valued at 90 million with 30 million in the bank.accordingly all other assets are valued at just 60 million

    I don't think subtracting cash from the market cap to get an enterprise or technology value makes sense for biotech companies with no income. The cash is going to be needed. A better approach would be to *add* a "cost of capital" sum (or multiplier to reflect dilution from future equity issues) to companies that *don't* have cash.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.8¢
Change
0.000(0.00%)
Mkt cap ! $7.366M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
5 883823 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 500697 1
View Market Depth
Last trade - 16.21pm 30/07/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.